May 18, 2017 / 9:02 PM / 3 months ago

BRIEF-Xbiotech says received negative opinion for its lead product candidate in Europe

May 18 (Reuters) - Xbiotech Inc

* Xbiotech - received negative opinion from EMA CHMP for marketing authorization application for its lead product candidate in Europe

* Xbiotech - co plans to promptly notify EMA of its request for a re-examination and will have 60 days to submit its grounds for appeal - SEC filing Source text for Eikon: (bit.ly/2q153RU) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below